Coloplast ASB reports Q3 results

seekingalpha08-20

Coloplast ASB press release (OTCPK:CLPBF): Q3 EBIT was DKK1.87B, an 11% increase from last year. The EBIT margin was 27% against 28% last year. Revenue of DKK6.89B (+13% Y/Y) FY 2023/24 guidance ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2460021318?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-20 16:24","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2460021318","market":"fut","top_or_hot":-1,"title":"Coloplast ASB reports Q3 results","media":"seekingalpha","content":"<div>\n<p>Coloplast ASB press release (OTCPK:CLPBF): Q3 EBIT was DKK1.87B, an 11% increase from last year.  The EBIT margin was 27% against 28% last year. Revenue of DKK6.89B (+13% Y/Y) FY 2023/24 guidance ...</p>\n\n<a href=\"https://seekingalpha.com/news/4141717-coloplast-asb-reports-q3-results\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coloplast ASB reports Q3 results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nColoplast ASB reports Q3 results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-20 16:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4141717-coloplast-asb-reports-q3-results><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Coloplast ASB press release (OTCPK:CLPBF): Q3 EBIT was DKK1.87B, an 11% increase from last year.  The EBIT margin was 27% against 28% last year. Revenue of DKK6.89B (+13% Y/Y) FY 2023/24 guidance ...</p>\n\n<a href=\"https://seekingalpha.com/news/4141717-coloplast-asb-reports-q3-results\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLPBF","symbol_name":"Coloplast AS","start_time":0,"source_url":"https://seekingalpha.com/news/4141717-coloplast-asb-reports-q3-results","article_id":"2460021318","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2460021318","pubTimestamp":1724142242,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Coloplast ASB press release : Q3 EBIT was DKK1.87B, an 11% increase from last year.  The EBIT margin was 27% against 28% last year. Revenue of DKK6.89B  FY 2023/24 guidance unchanged. The organic revenue growth is expected to be around 8%. Reported growth in DKK is expected to be 10-11% with negative impact of 1-2%-points from currencies and around 4%-points contribution from the acquisition of Kerecis .  The reported EBIT margin before special items is expected to be 27-28%. The EBIT margin includes around 100 basis points dilution from Kerecis  and negative impact from currencies.  Capital expenditures expectations adjusted to around DKK 1.3 billion.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLPBF":"Coloplast AS","BK4198":"医疗保健用品","ASB":"Associated Banc-Corp","BK4211":"区域性银行"},"translate_title":"康乐保ASB报告第三季度业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ASB":1,"CLPBF":1},"content_text":"Coloplast ASB press release (OTCPK:CLPBF): Q3 EBIT was DKK1.87B, an 11% increase from last year.  The EBIT margin was 27% against 28% last year. Revenue of DKK6.89B (+13% Y/Y) FY 2023/24 guidance unchanged. The organic revenue growth is expected to be around 8%. Reported growth in DKK is expected to be 10-11% with negative impact of 1-2%-points from currencies and around 4%-points contribution from the acquisition of Kerecis (11 months).  The reported EBIT margin before special items is expected to be 27-28%. The EBIT margin includes around 100 basis points dilution from Kerecis (incl. around DKK 100 million in PPA amortisation) and negative impact from currencies. • Capital expenditures expectations adjusted to around DKK 1.3 billion.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460021318"}